PDA Technical Report No. 69, (TR 69) Bioburden and Biofilm Management in Pharmaceutical Manufacturing Operations presents the current scientific understanding of the causes of and control strategies for bioburden in pharmaceutical production systems, with a special emphasis on biofilms in fluid-handling systems. It encompasses pharmaceutical and biopharmaceutical manufacturing processes, but does not include the final aseptic and terminal sterilization fill-finish operations.
More Standards PDF
PIP CTCE1000-EEDS
$62.00 $125.00
PIP PN09CM1S01
$37.00 $75.00
PIP PN03CL1S01
$37.00 $75.00
PIP PN15CJ1S01
$37.00 $75.00